5-year Outcomes from the Randomized CoreValve US Pivotal High Risk Trial: Final Results

被引：1
|
作者：
Gleason, Thomas [1 ]
Reardon, Michael [2 ]
Popma, Jeffrey [3 ]
Lee, Joon [4 ]
Kleiman, Neal [2 ]
Chetcuti, Stanley [5 ]
Deeb, G. Michael [6 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[5] Univ Michigan, Ctr Hlth, Ann Arbor, MI 48109 USA
[6] Univ Michigan Hosp, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2018.08.1090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-13
引用
收藏
页码：B6 / B6
页数：1
相关论文
共 50 条
  • [1] Causes of death from the randomized CoreValve US Pivotal High-Risk Trial
    Gaudiani, Vincent
    Deeb, Michael
    Popma, Jeffrey J.
    Adams, David H.
    Gleason, Thomas G.
    Conte, John V.
    Zorn, George L., III
    Hermiller, James B., Jr.
    Chetcuti, Stan
    Mumtaz, Mubashir
    Yakubov, Steven J.
    Kleiman, Neal S.
    Huang, Jian
    Reardon, Michael J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (06): : 1293 - 1299
  • [2] Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial
    Arnold, Suzanne V.
    Petrossian, George
    Reardon, Michael J.
    Kleiman, Neal S.
    Yakubov, Steven J.
    Wang, Kaijun
    Hermiller, James, Jr.
    Harrison, J. Kevin
    Deeb, G. Michael
    Huang, Jian
    Cohen, David J.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (06) : 620 - 627
  • [3] Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less
    Reardon, Michael J.
    Kleiman, Neal S.
    Adams, David H.
    Yakubov, Steven J.
    Coselli, Joseph S.
    Deeb, G. Michael
    O'Hair, Daniel
    Gleason, Thomas G.
    Lee, Joon Sup
    Hermiller, James B., Jr.
    Chetcuti, Stan
    Heiser, John
    Merhi, William
    Zorn, George L., III
    Tadros, Peter
    Robinson, Newell
    Petrossian, George
    Hughes, G. Chad
    Harrison, J. Kevin
    Maini, Brijeshwar
    Mumtaz, Mubashir
    Conte, John V.
    Resar, Jon R.
    Aharonian, Vicken
    Pfeffer, Thomas
    Oh, Jae K.
    Huang, Jian
    Popma, Jeffrey J.
    JAMA CARDIOLOGY, 2016, 1 (08) : 945 - 949
  • [4] The 5-year data on degeneration of biological aortic valves show advantages for self-expanding TAVI valves in comparison to surgical aortic valve prostheses Results from the randomized CoreValve US High Risk Pivotal and SURTAVI studies
    Werner, Nikos
    KARDIOLOGIE, 2023, 17 (02): : 111 - 112
  • [5] Final 5-year results of Z-FAST trial
    Brufsky, Adam M.
    Harker, W. Graydon
    Beck, J. Thaddeus
    Bosserman, Linda
    Vogel, Charles
    Seidler, Christopher
    Jin, Lixian
    Warsi, Ghulam
    Argonza-Aviles, Eliza
    Hohneker, John
    Ericson, Solveig G.
    Perez, Edith A.
    CANCER, 2012, 118 (05) : 1192 - 1201
  • [6] Durability of the Quality of Life Benefit of Transcatheter or Surgical Aortic Valve Replacement in High Risk Patients with Aortic Stenosis: Two-Year Results From the CoreValve US Pivotal High Risk Trial
    Baron, Suzanne J.
    Arnold, Suzanne V.
    Reynolds, Matthew R.
    Caskey, Michael P.
    Byrne, Timothy J.
    Ferdinand, Leya
    Adams, David
    Popma, Jeffrey
    Cohen, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B54 - B55
  • [7] OUTCOMES IN THE COREVALVE US HIGH-RISK PIVOTAL TRIAL IN PATIENTS WITH A SOCIETY OF THORACIC SURGEONS PREDICTED RISK OF MORTALITY LESS THAN OR EQUAL TO 7
    Reardon, Michael J.
    Adams, David
    Kleiman, Neal
    Deeb, G. Michael
    Yakubov, Steven
    Zorn, George
    Popma, Jeffrey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 121 - 121
  • [8] CLINICAL OUTCOMES AT 5 YEARS FOLLOWING SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE COREVALVE US EXTREME RISK PIVOTAL TRIAL
    Petrossian, George
    Hermiller, James
    Yakubov, Steven J.
    Reardon, Michael
    Deeb, G. Michael
    Adams, David
    Popma, Jeffrey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 997 - 997
  • [9] HEALTH STATUS AFTER TRANSCATHETER OR SURGICAL AORTIC VALVE REPLACEMENT IN HIGH RISK PATIENTS WITH SEVERE AORTIC STENOSIS: RESULTS FROM THE COREVALVE US PIVOTAL TRIAL
    Arnold, Suzanne
    Reynolds, Matthew
    Wang, Kaijun
    Magnuson, Elizabeth
    Baron, Suzanne
    Chinnakondepalli, Khaja
    Reardon, Michael
    Tadros, Peter
    Zorn, George
    Maini, Brijeshwar
    Mumtaz, Mubashir
    Brown, John
    Kippertnan, Robert
    Adams, David
    Popma, Jeffrey
    Cohen, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1999 - A1999
  • [10] Clinical Outcomes of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Final 5-Year Results From the ABSORB III Trial
    Ellis, Stephen
    Kereiakes, Dean
    Stone, Gregg
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B166 - B166
12345